Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Francois van Loggerenberg

Biographic Data

ID7728636
NAMEFrancois van Loggerenberg
GIVEN NAMESFrancois
FAMILY NAMEvan Loggerenberg
SIGNATUREVAN LOGGERENBERG F
AFFILIATIONSCentre for the AIDS Programme of Research in South Africa
ORCID0000-0001-5317-7983
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2013
LATEST PUBLICATION YEAR2015
H-INDEX0
  • Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting

    Open Access•Nivashnee Naicker, Ayesha B M Kharsany et al.•ARTICLE•AIDS and Behavior•2015

  • Trial participation disclosure and gel use behavior in the Caprisa 004 tenofovir gel trial

    Stacey Succop, Stacey M Succop et al.•ARTICLE•AIDS Care•2014

    Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' trial product usage behavior and contribute to poor adherence. With mixed results from recent microbicide clinical trials being linked to differing participant adherence, insights into the communication dynamics between trial participants and their s…

  • Impact of Antiretroviral Therapy on Health-Related Quality of Life among South African Women in the Caprisa 002 Acute Infection Study

    Open Access•Andrew Tomita, Nigel Garrett et al.•ARTICLE•AIDS and Behavior•2014

  • Assessing Adherence in the Caprisa 004 Tenofovir Gel HIV Prevention Trial

    Open Access•Kathleen M Macqueen, Mark A Weaver et al.•ARTICLE•AIDS and Behavior•2014

    Adherence undeniably impacts product effectiveness in microbicide trials, but the connection has proven challenging to quantify using routinely collected behavioral data. We explored this relationship using a nested case-control study in the CAPRISA 004 Tenofovir (TFV) gel HIV prevention trial. Detailed 3-month recall data on sex events, condom and gel use were collected from 72 incident cases and 205 uninfected controls. We then assessed how the…

  • Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients

    Open Access•Francois van Loggerenberg, Anne D Grant et al.•ARTICLE•AIDS and Behavior•2014

  • Health-Related Quality of Life Dynamics of HIV-positive South African Women up to ART Initiation

    Open Access•Andrew Tomita, Nigel Garrett et al.•ARTICLE•AIDS and Behavior•2013

  • HIV Transmission Risk Behavior Among HIV-Positive Patients Receiving Antiretroviral Therapy in KwaZulu-Natal, South Africa

    Open Access•Paul A Shuper, Susan M Kiene et al.•ARTICLE•AIDS and Behavior•2013

No prominent works on this page.

  • Health-Related Quality of Life Dynamics of HIV-positive South African Women up to ART Initiation

    Open Access•Andrew Tomita, Nigel Garrett et al.•ARTICLE•AIDS and Behavior•2013

  • HIV Transmission Risk Behavior Among HIV-Positive Patients Receiving Antiretroviral Therapy in KwaZulu-Natal, South Africa

    Open Access•Paul A Shuper, Susan M Kiene et al.•ARTICLE•AIDS and Behavior•2013

  • Trial participation disclosure and gel use behavior in the Caprisa 004 tenofovir gel trial

    Stacey Succop, Stacey M Succop et al.•ARTICLE•AIDS Care•2014

    Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' trial product usage behavior and contribute to poor adherence. With mixed results from recent microbicide clinical trials being linked to differing participant adherence, insights into the communication dynamics between trial participants and their s…

  • Impact of Antiretroviral Therapy on Health-Related Quality of Life among South African Women in the Caprisa 002 Acute Infection Study

    Open Access•Andrew Tomita, Nigel Garrett et al.•ARTICLE•AIDS and Behavior•2014

  • Assessing Adherence in the Caprisa 004 Tenofovir Gel HIV Prevention Trial

    Open Access•Kathleen M Macqueen, Mark A Weaver et al.•ARTICLE•AIDS and Behavior•2014

    Adherence undeniably impacts product effectiveness in microbicide trials, but the connection has proven challenging to quantify using routinely collected behavioral data. We explored this relationship using a nested case-control study in the CAPRISA 004 Tenofovir (TFV) gel HIV prevention trial. Detailed 3-month recall data on sex events, condom and gel use were collected from 72 incident cases and 205 uninfected controls. We then assessed how the…

  • Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients

    Open Access•Francois van Loggerenberg, Anne D Grant et al.•ARTICLE•AIDS and Behavior•2014

  • Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting

    Open Access•Nivashnee Naicker, Ayesha B M Kharsany et al.•ARTICLE•AIDS and Behavior•2015

HIV/AIDS Research and Interventions (7 works) · Medicine (7 works) · Health psychology (6 works) · Human immunodeficiency virus (HIV (6 works) · Internal Medicine (6 works) · Public health (6 works) · Adolescent Sexual and Reproductive Health (5 works) · Clinical Psychology (5 works) · Clinical Psychology (4 works) · Family medicine (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae